Literature DB >> 11046153

Distinct p300-responsive mechanisms promote caspase-dependent apoptosis by human T-cell lymphotropic virus type 1 Tax protein.

C Nicot1, R Harrod.   

Abstract

The dysregulation of cellular apoptosis pathways has emerged as a critical early event associated with the development of many types of human cancers. Numerous viral and cellular oncogenes, aside from their inherent transforming properties, are known to induce programmed cell death, consistent with the hypothesis that genetic defects are required to support tumor survival. Here, we report that nuclear expression of the CREB-binding protein (CBP)/p300-binding domain of the human T-cell lymphotropic virus type 1 (HTLV-1) transactivator, Tax, triggers an apoptotic death-inducing signal during short-term clonal analyses, as well as in transient cell death assays. Coexpression of the antiapoptotic factor Bcl-2 increased serum stimulation; incubation with the chemical caspase inhibitor z-Val-Ala-DL-Asp fluoromethylketone antagonized Tax-induced cell death. The CBP/p300-binding defective Tax mutants K88A and V89A exhibited markedly reduced cytotoxic effects compared to the wild-type Tax protein. Importantly, nuclear expression of the minimal CBP/p300-binding peptide of Tax induced apoptosis in the absence of Tax-dependent transcriptional activities, while its K88A counterpart did not cause cell death. Further, Tax-mediated apoptosis was effectively prevented by ectopic expression of the p300 coactivator. We also report that activation of the NF-kappaB transcription pathway by Tax, under growth arrest conditions, results in apoptosis that occurs independent of direct Tax coactivator effects. Our results allude to a novel pivotal role for the transcriptional coactivator p300 in determining cell fate and raise the possibility that dysregulated coactivator usage may pose an early barrier to transformation that must be selectively overcome as a prerequisite for the initiation of neoplasia.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11046153      PMCID: PMC102163          DOI: 10.1128/MCB.20.22.8580-8589.2000

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  61 in total

1.  Function for p300 and not CBP in the apoptotic response to DNA damage.

Authors:  Z M Yuan; Y Huang; T Ishiko; S Nakada; T Utsugisawa; H Shioya; Y Utsugisawa; Y Shi; R Weichselbaum; D Kufe
Journal:  Oncogene       Date:  1999-10-07       Impact factor: 9.867

Review 2.  Persistent activation of NF-kappaB by the tax transforming protein of HTLV-1: hijacking cellular IkappaB kinases.

Authors:  S C Sun; D W Ballard
Journal:  Oncogene       Date:  1999-11-22       Impact factor: 9.867

Review 3.  Control of apoptosis by Rel/NF-kappaB transcription factors.

Authors:  M Barkett; T D Gilmore
Journal:  Oncogene       Date:  1999-11-22       Impact factor: 9.867

4.  Apoptotic response to growth factor deprivation involves cooperative interactions between c-Fos and p300.

Authors:  G A Preston; D Srinivasan; J C Barrett
Journal:  Cell Death Differ       Date:  2000-02       Impact factor: 15.828

Review 5.  Cells en route to apoptosis are characterized by the upregulation of c-fos, c-myc, c-jun, cdc2, and RB phosphorylation, resembling events of early cell-cycle traverse.

Authors:  S Pandey; E Wang
Journal:  J Cell Biochem       Date:  1995-06       Impact factor: 4.429

6.  Bcl-X(L) is up-regulated by HTLV-I and HTLV-II in vitro and in ex vivo ATLL samples.

Authors:  C Nicot; R Mahieux; S Takemoto; G Franchini
Journal:  Blood       Date:  2000-07-01       Impact factor: 22.113

7.  HTLV-I Tax transrepresses the human c-Myb promoter independently of its interaction with CBP or p300.

Authors:  C Nicot; R Mahieux; R Opavsky; A Cereseto; L Wolff; J N Brady; G Franchini
Journal:  Oncogene       Date:  2000-04-20       Impact factor: 9.867

8.  p300 and p300/cAMP-responsive element-binding protein associated factor interact with human T-cell lymphotropic virus type-1 Tax in a multi-histone acetyltransferase/activator-enhancer complex.

Authors:  R Harrod; Y L Kuo; Y Tang; Y Yao; A Vassilev; Y Nakatani; C Z Giam
Journal:  J Biol Chem       Date:  2000-04-21       Impact factor: 5.157

Review 9.  Apoptosis in the pathogenesis and treatment of disease.

Authors:  C B Thompson
Journal:  Science       Date:  1995-03-10       Impact factor: 47.728

10.  Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma.

Authors:  B J Poiesz; F W Ruscetti; A F Gazdar; P A Bunn; J D Minna; R C Gallo
Journal:  Proc Natl Acad Sci U S A       Date:  1980-12       Impact factor: 11.205

View more
  21 in total

Review 1.  Comparative biology of human T-cell lymphotropic virus type 1 (HTLV-1) and HTLV-2.

Authors:  Gerold Feuer; Patrick L Green
Journal:  Oncogene       Date:  2005-09-05       Impact factor: 9.867

2.  Acetylation of the c-MYC oncoprotein is required for cooperation with the HTLV-1 p30(II) accessory protein and the induction of oncogenic cellular transformation by p30(II)/c-MYC.

Authors:  Megan M Romeo; Bookyung Ko; Janice Kim; Rebecca Brady; Hayley C Heatley; Jeffrey He; Carolyn K Harrod; Braden Barnett; Lee Ratner; Michael D Lairmore; Ernest Martinez; Bernhard Lüscher; Craig N Robson; Marie Henriksson; Robert Harrod
Journal:  Virology       Date:  2015-01-05       Impact factor: 3.616

3.  miR-28-3p is a cellular restriction factor that inhibits human T cell leukemia virus, type 1 (HTLV-1) replication and virus infection.

Authors:  Xue Tao Bai; Christophe Nicot
Journal:  J Biol Chem       Date:  2015-01-07       Impact factor: 5.157

4.  The human T-cell leukemia virus type-1 tax oncoprotein dissociates NF-κB p65RelA-Stathmin complexes and causes catastrophic mitotic spindle damage and genomic instability.

Authors:  Aditi Malu; Tetiana Hutchison; Laçin Yapindi; Katie Smith; Katherine Nelson; Rachel Bergeson; Jordan Pope; Megan Romeo; Carolyn Harrod; Lee Ratner; Carine Van Lint; Robert Harrod
Journal:  Virology       Date:  2019-07-03       Impact factor: 3.616

5.  Paradoxical effects of a stress signal on pro- and anti-apoptotic machinery in HTLV-1 Tax expressing cells.

Authors:  Cynthia de la Fuente; Lai Wang; Dai Wang; Longwen Deng; Kaili Wu; Hong Li; L Dana Stein; Thomas Denny; Frederick Coffman; Kylene Kehn; Shanese Baylor; Anil Maddukuri; Anne Pumfery; Fatah Kashanchi
Journal:  Mol Cell Biochem       Date:  2003-03       Impact factor: 3.396

Review 6.  Molecular biology and pathogenesis of the human T-cell leukaemia/lymphotropic virus Type-1 (HTLV-1).

Authors:  J M Johnson; R Harrod; G Franchini
Journal:  Int J Exp Pathol       Date:  2001-06       Impact factor: 1.925

Review 7.  T-cell control by human T-cell leukemia/lymphoma virus type 1.

Authors:  Genoveffa Franchini; Risaku Fukumoto; Jake R Fullen
Journal:  Int J Hematol       Date:  2003-11       Impact factor: 2.490

8.  Suppression of PTEN expression by NF-kappa B prevents apoptosis.

Authors:  Krishna Murthi Vasudevan; Sushma Gurumurthy; Vivek M Rangnekar
Journal:  Mol Cell Biol       Date:  2004-02       Impact factor: 4.272

9.  HTLV-I Tax-dependent and -independent events associated with immortalization of human primary T lymphocytes.

Authors:  Marcia Bellon; Hicham H Baydoun; Yuan Yao; Christophe Nicot
Journal:  Blood       Date:  2010-01-21       Impact factor: 22.113

Review 10.  HTLV-1 and apoptosis: role in cellular transformation and recent advances in therapeutic approaches.

Authors:  John M Taylor; Christophe Nicot
Journal:  Apoptosis       Date:  2008-06       Impact factor: 4.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.